<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Fungal infections caused by dermatophytes and yeasts of 
 <italic class="italic">Candida</italic> spp., are a serious health problem in immunocompromised patients in particular and are aggravated by the increase in clinical resistance to the antifungal agents (
 <xref rid="ref-46" ref-type="bibr" class="xref">Silva et al., 2012</xref>; 
 <xref rid="ref-33" ref-type="bibr" class="xref">Morais-Braga et al., 2016b</xref>). In view of this problem, the interest in the use of vegetable derivatives with therapeutic potential for antifungal action has intensified (
 <xref rid="ref-27" ref-type="bibr" class="xref">Macêdo et al., 2015</xref>). These new substances of plant origin may represent alternative and less toxic treatments for the treatment of infections (
 <xref rid="ref-52" ref-type="bibr" class="xref"> Vandeputte, Ferrari &amp; Coste, 2011</xref>), synergism and inhibition of germ tube formation by compounds derived from 
 <italic class="italic">Crocus sativus</italic> against 
 <italic class="italic">Candida</italic> spp (
 <xref rid="ref-6" ref-type="bibr" class="xref"> Carradori et al., 2016</xref>). Considering the medicinal importance of the genus 
 <italic class="italic">Psidium</italic> and the absence of studies with 
 <italic class="italic">Psidium salutare</italic>, this is the first study to describe the chemical profile of 
 <italic class="italic">P. salutare</italic> leaf essential oil, and the influence of seasonal variation on its composition, antifungal activity and potency to inhibit the morphogenetic switch in 
 <italic class="italic">Candida</italic> species.
</p>
